Abstract
Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin with high rates of local recurrence and distant metastases despite treatment with traditional cytotoxic chemotherapies. The recent advances in immunotherapy, including the use of immune checkpoint blockade (ICB) has revolutionized treatment for this disease and resulted in durable responses for some patients. However, many patients, due to underlying conditions, have been insufficiently evaluated for potential use of immunotherapy. Here we present a case of ICB treatment with Programmed cell death protein 1 (PD-1) inhibition in a patient with underlying interstitial lung disease (ILD) and a new diagnosis of MCC. Through a multidisciplinary approach, we were able to maintain close monitoring with serial clinical and radiographical follow-up. The patient achieved a complete response though unrelated medical issues resulting in a treatment hold. At the last follow-up, the patient continued to experience a durable response without evidence of recurrence. This case describes the use of pembrolizumab, a PD-1 inhibitor, for the treatment of MCC in a patient with underlying ILD. The use of active surveillance with a multidisciplinary approach resulted in successful ...Continue Reading
References
Dec 12, 2000·The Journal of Allergy and Clinical Immunology·J A Vanden BurgtD Donnell
Nov 18, 2003·British Journal of Clinical Pharmacology·N R Labiris, M B Dolovich
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey WeberSteven J O'Day
Apr 20, 2016·The New England Journal of Medicine·Paul T NghiemMartin A Cheever
Jul 20, 2016·Cancer Medicine·Jayasri G IyerPaul Nghiem
Sep 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jarushka NaidooMatthew D Hellmann
Jun 21, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Monica Khunger, Vamsidhar Velcheti
Aug 26, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Daichi FujimotoKeisuke Tomii
Oct 7, 2017·Cancer Immunology, Immunotherapy : CII·Daniel FranzenMalcolm Kohler
Nov 6, 2017·Journal of the American Academy of Dermatology·Kelly G PaulsonPaul Nghiem
Dec 13, 2017·Journal of the American Academy of Dermatology·Tiffany L TelloSiegrid S Yu
May 22, 2018·Thoracic Cancer·Osamu KanaiToyohiro Hirai
Feb 7, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul NghiemSuzanne L Topalian